Zafgen, Inc. (NASDAQ:ZFGN) enjoyed a 12% run-up in share price since hitting record low of $1.25. The stock managed 4.48% rise and now stands at $1.4 as of 6/12/2019. At a recent session, the prices were hovering between $1.25 and $1.43. This company shares are 352.14% off its target price of $6.33 and the current market capitalization stands at $52.99M. The recent change has given its price a -42.89% deficit over SMA 50 and -88.67% deficit over its 52-week high. The stock witnessed -45.74% declines, -53.18% declines and -72.71% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found ZFGN’s volatility during a week at 12.81% and during a month it has been found around 9.37%.Zafgen, Inc. (ZFGN) Top Holders
Institutional investors currently hold around $40 million or 82.1% in ZFGN stock. Look at its top three institutional owners: Atlas Venture Advisors, Inc. owns $4.7 million in Zafgen, Inc., which represents roughly 8.87% of the company’s market cap and approximately 11.75% of the institutional ownership. Similar statistics are true for the second largest owner, Great Point Partners I Lp, which owns 3,110,874 shares of the stock are valued at $4.17 million. The third largest holder is Blackrock Inc., which currently holds $3.37 million worth of this stock and that ownership represents nearly 6.37% of its market capitalization.
At the end of March reporting period, 43 institutional holders increased their position in Zafgen, Inc. (NASDAQ:ZFGN) by some 3,970,239 shares, 45 decreased positions by 5,583,753 and 19 held positions by 20,489,831. That puts total institutional holdings at 30,043,823 shares, according to SEC filings. The stock grabbed 12 new institutional investments totaling 483,581 shares while 20 institutional investors sold out their entire positions totaling 2,730,171 shares.Zafgen, Inc. (NASDAQ:ZFGN) Insider Trades
Multiple company employees have indulged in significant insider trading. Zafgen, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Hughes Thomas E. has sold 32,000 shares of Zafgen, Inc. (ZFGN) in the trading session dated Jun. 28, 2018. These shares are worth $320,000 and were traded at $10 each. The SEC filing shows that Hughes Thomas E. performed a sale of 5,000 shares. The disposed these shares by way of transaction on Mar. 07, 2018. The company’s shares were given away at $10 per share worth to an income of some $50,000 to the account of Hughes Thomas E..
Director, Heller Frances K, purchased 10,000 common shares of Zafgen, Inc. (ZFGN) in the open market. In a transaction dated Oct. 13, 2017, the shares were bought at an average price of $3.9, giving away a sum of $39,000. After this purchase, 47,961 common shares of ZFGN are directly owned by the insider, with total stake valued at $67,145.
In the transaction dated Jul. 11, 2017, a great number of shares acquired came courtesy the Chief Medical Officer; KIM DENNIS D added a total of 10,000 shares at an average price of $3.39, amounting to approximately $33,900. The insider now directly owns 21,443 shares worth $30,020.
Several analysts have released their opinion on Zafgen, Inc. (NASDAQ:ZFGN), with 2 analysts believing it is a strong buy. Whereas 1 of them predict the stock is a hold. Also, there are 3 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.83 average brokerage recommendation [T1].